Önder, ElifAlbayrak, HülyaGürlevik, ZehraAydın, Yusuf2020-04-302020-04-3020101307671Xhttps://hdl.handle.net/20.500.12684/243Stevens Johnson Syndrome (SJS) is a life threatening mucocutaneous skin disease that mostly developed after using some drug. SJS mostly appear between 2-4th decades. Mucocutaneous lesions were seen between 1-14 days of drug intake. And these lesions spread diffusely all around the body. First treatment choice is the stopping of drug that cause SJS and giving supporting treatment. After understanding of underlying cytotoxic and immunological mechanism of SJS, new treatment approaches were developed and mortality of disease was reduced. We herein report a short review of drug induced SJS and its treatment. © 2010 Düzce Medical Journal.trinfo:eu-repo/semantics/closedAccessDrugs; Stevens Johnson syndromeReview Article12198103Q4